• Decitabine: Mechanism and Cancer Epigenetics

  2026-09-18

  Decitabine, also called 5-Aza-2'-deoxycytidine, is a DNA methyltransferase inhibitor that can produce DNA hypomethylation and epigenetically reactivate silenced genes. Its research value spans hematopoietic malignancy research, solid tumor epigenetic studies, and tumor suppressor gene reactivation, but molecular-dose effects must be separated from clinical indications.

• SU5416 (Semaxanib): From Mechanism to Translation

  2026-09-18

  SU5416 (Semaxanib) offers translational researchers a controllable way to interrogate VEGFR2-driven endothelial biology while accounting for its additional aryl hydrocarbon receptor activity. This thought-leadership article connects molecular perturbation to angiogenesis, tumor vascularization, immune context, and pulmonary vascular hemodynamics, providing a practical framework for stronger experimental interpretation.

• SCH772984: An ERK1/2 Lens on NPC Radioresistance

  2026-09-17

  A translational framework for testing whether ERK1/2 connects angiotensin II–HIF-1α–HILPDA signaling, ferroptosis suppression, and radiotherapy resistance in nasopharyngeal carcinoma.

• GPNMB Model Predicts Immunotherapy Response in ESCC

  2026-09-17

  This study identifies circulating soluble GPNMB as a mechanistically linked biomarker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal framework with potential value for treatment stratification and translational biomarker research.

• Ceftolozane/Tazobactam: Resistant Gram-Negative Infections

  2026-09-16

  The 2015 review of ceftolozane/tazobactam explains how a focused antipseudomonal cephalosporin paired with tazobactam addresses important resistance mechanisms in gram-negative pathogens. Its synthesis of mechanism, pharmacokinetics, pharmacodynamics, clinical evidence, and safety provides a practical framework for interpreting this combination in complicated intraabdominal and urinary tract infections.

• Polybrene: Mechanism and Workflow Guide

  2026-09-16

  Polybrene, also called Hexadimethrine Bromide, is a cationic polymer used to improve viral gene delivery and selected lipid-mediated DNA transfection workflows. The 10 mg/mL formulation supports reproducible handling, but exposure duration and cell-specific toxicity require empirical optimization.

• MLKL-Driven Lysosomal Permeabilization in Necroptosis

  2026-09-15

  The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a mechanistic link between necrosome activation and necroptotic cell death. Imaging, perturbation, and MLKL domain experiments place cathepsin B release downstream of lysosomal damage and show that this protease contributes substantially to cell killing.

• Cefoperazone: From β-Lactam Biology to Translation

  2026-09-15

  Cefoperazone sodium salt offers translational researchers a practical model for connecting β-lactamase stability, organism-specific antibacterial activity, assay design, and biliary distribution. This thought-leadership article places Cefoperazone within historical comparative data while outlining a more rigorous path from in vitro antimicrobial activity assay results to infection-model decisions.

• IPR-803: Urokinase Receptor Inhibitor Workflows

  2026-09-14

  IPR-803 is a mechanistically defined urokinase receptor inhibitor for testing uPAR–uPA biology in invasion, metastasis, angiogenesis, and tumor-stroma workflows. Its strongest value comes from pairing biochemical competition assays with orthogonal cell-based and pharmacokinetic measurements rather than treating reduced viability as the primary endpoint.

• ABT-199 (Venetoclax): Selective Bcl-2 Inhibitor

  2026-09-14

  ABT-199, also known as Venetoclax and GDC-0199, is a potent, selective BCL-2 inhibitor for mechanistic apoptosis research. Its reported selectivity over BCL-XL, BCL-w, and MCL-1 supports focused studies of the mitochondrial apoptosis pathway in hematologic malignancy models.

• Z-VDVAD-FMK: Mapping Apoptosis in NSCLC

  2026-09-13

  A translational guide to using Z-VDVAD-FMK to distinguish caspase-2-linked mitochondrial apoptosis from caspase-1-driven pyroptosis, with practical validation strategies for cancer research.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-09-12

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia cell proliferation and survival. By combining protein-interaction analysis, genetic perturbation, transcriptomics, chromatin profiling, rescue experiments, and in vivo validation, it connects LDB1-dependent transcriptional regulation with AML maintenance and highlights a potentially actionable regulatory axis.

• Temafloxacin and Combination Activity Against M. avium

  2026-09-11

  The 1993 Journal of Antimicrobial Chemotherapy study evaluated clarithromycin, Temafloxacin, and ethambutol against 20 Mycobacterium avium complex strains using extracellular MIC/FIC testing and macrophage infection models. Its central finding was that combination activity was strain dependent, while the three-drug combination produced the strongest intracellular bactericidal effect, supporting phenotype-aware and compartment-specific antimicrobial testing.

• Polybrene: Practical Guide to Viral Transduction

  2026-09-11

  Polybrene (Hexadimethrine Bromide) improves viral attachment and uptake while also supporting difficult lipid-mediated DNA transfection workflows. This guide connects concentration screening, exposure control, and metabolic assay design to practical research use cases, including studies of the TCAIM–OGDH mitochondrial pathway.

• Hydrocortisone in EMT Splicing Assays

  2026-09-10

  Hydrocortisone is more than a glucocorticoid hormone supplement in cell culture. This guide explains how controlled hydrocortisone exposure should be interpreted when studying CLSTN1 splicing, EMT, and breast cancer metastasis.

8151 records 1/544 page Next 12345 下5页 Last page